NATURALLY SPLENDID ENTERPRISES LTD. (“Naturally Splendid” or “NSE”) (TSXV:NSP)(OTCQB:NSPDF)(FRANKFURT:50N) is pleased to announce that it proposes to acquire certain cannabinoid extraction equipment with a value of $1,025,000 CDN, (the “Extraction Equipment”) from Wahupta Ventures Inc. (“Wahupta”) by issuing a total of 5,540,541 common shares of Naturally Splendid.

To date, Wahupta has completed three financing tranches totaling $500,000 CDN under the previously announced Cooperation Agreement (see news release dated October 9, 2018).The acquisition of the Extraction Equipment, represents the final tranche of the renegotiated terms of the Cooperation Agreement.

Wahupta has significant expertise in the field of cannabinoid extraction through its wholly owned manufacturing subsidiary, Curran Technologies Inc. (CTI), which has designed a complete extraction facility and laboratory for Naturally Splendid. CTI is an industrial manufacturer of high quality, closed-loop extraction equipment, based out of Victoria, British Columbia, Canada. CTI’s principal manufactured extraction system, the high-efficiency Extract Pro series, is touted for its durability, scalability, and productivity.

As part of the final tranche of the Cooperation Agreement, Naturally Splendid will receive four extraction units from CTI including, three (3) Extract Pro RIV extraction unit and one (1) Extract Pro RIII extraction unit, as well as all required accessories to be a fully functional cannabinoid extraction facility (the “Extraction Facility”).

The scalable solutions offered by CTI will be optimized to facilitate the processing of a range of input biomass materials, into a variety of finished cannabinoid states whether that be isolate or full spectrum oils. Additionally, Wahupta will be designing and installing a functional laboratory to augment the services and equipment provided to Naturally Splendid.

Manufacturing of the Extraction Equipment has commenced, with final testing scheduled to be completed in a strategic timeframe in order for Naturally Splendid to receive the appropriate licensing from Health Canada. The Extraction Facility will be completed in NSE’s Pitt Meadows manufacturing facility in BC, Canada.

Wahupta CEO Mr. Warren Cudney states, “I know the industry is all about bigger is better. And that is a reasonable assumption to a point. However, we have developed an extraction strategy with Naturally Splendid that utilizes multiple, scalable batch units. The fact is cannabinoid extraction in Canada is still relatively new. The extraction technologies are advanced and commercially viable. It’s the preparation of input biomass material that is still being optimized throughout the industry. Smaller batch units allow for multiple test runs to optimize outputs while minimizing loss of valuable biomass for testing. It is our experience that while the extraction technology is advanced, the farming, cultivating, harvesting and preparing of biomass is still very much an evolving science. With these units, we can begin to work with farmers determining how to best harvest in a manner that allows for maximum yields from various biomass forms.”

Naturally Splendid V.P. of Operations & Co-Founder Bryan Carson states, “At NSE we understand how to scale up from concept to retail-ready product. Product development is done in incremental steps. Therefore, the flexibility that multiple small batch extraction systems affords us will create a competitive advantage when it comes to product development. This methodology allows for more testing of products through an R&D strategy, creating a much more efficient Product Development process.

Additionally, NSE and Wahupta will work towards finalizing another Cooperation Agreement that will see the Companies leverage their combined expertise and services in the cannabinoid extraction markets.

Naturally Splendid CEO Mr. Douglas Mason reports, “This is a historic day for NSE as we begin the process of building out our cannabinoid extraction facility. Naturally Splendid Extracts is continuing its application process for a standard processing license for a cannabinoid extraction facility under the Cannabis Act(Canada) and the construction of the facility is a critical step in the process of securing the required licensing from Health Canada. We are pleased to advance our subsidiary, Naturally Splendid Extraction to this stage and look forward to the multitude of opportunities working with Wahupta.”

Over the past twelve months, Naturally Splendid has begun to position itself to be a significant player in the evolving CBD markets by aggressively expanding its existing distribution reach through its non-CBD retail lines such as Natera™ Hemp Foods, Natera Sport ™, Natera FX™, Elevate Me™ and Pawsitive FX™, as well as through NSE’s many Contract Manufacturing Clients that have products being sold at most major retailers across Canada. Currently, Naturally Splendid retail lines are formulated and marketed without CBD fortification. However, once regulations allow for CBD edibles and beverages, NSE will have a built-in distribution network throughout North America.

CBD regulations in Canada are expected to be amended in 2019 to allow for CBD infused edibles, nutraceuticals and beverages. Health Canada will be holding sessions in the spring of 2019 to develop the proposed regulations pertaining to cannabinoid processing and sale.

Naturally Splendid President and Founder Mr. Craig Goodwin states, “We have evolved our strategic business plan from that of solely retail products, to a much more vertically integrated business model that currently includes our own manufacturing for hemp seeds, protein & oil, as well as our nutritional bar manufacturing facility. The addition of a cannabinoid extraction facility for CBD (cannabidiol) further enhances the services and products we can offer our clients. We are looking forward to processing the Wahupta biomass and to building a strong brand of CBD based products co-operatively with Wahupta, utilizing our various manufacturing facilities.”

Closing of the acquisition of the Extraction Equipment and issuance of the shares is subject to and acceptance of the TSX Venture Exchange.


Please visit for more information.

About Naturally Splendid Enterprises Ltd.

Naturally Splendid is a biotechnology and consumer products company that is developing, producing, commercializing, and licensing an entirely new generation of plant-derived, bioactive ingredients, nutrient dense foods, and related products. Naturally Splendid is building an expanding portfolio of patents (issued and pending) and proprietary intellectual property focused on the commercial uses of industrial hemp cannabinoid compounds in a broad spectrum of applications.

For more information e-mail or call Investor Relations at 604-673-9573

On Behalf of the Board of Directors
Mr. Douglas Mason
CEO, Director

Contact Information

Naturally Splendid Enterprises Ltd.
(NSP – TSX Venture; NSPDF – OTCQB; 50N Frankfurt)
#108-19100 Airport Way
Pitt Meadows, BC, V3Y 0E2
Office:  (604) 465-0548
Fax:      (604) 465-1128


Forward-Looking Statements

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Naturally Splendid cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Naturally Splendid’s control including, Naturally Splendid’s ability to compete with large food and beverage companies; sales of any potential products developed will be profitable; sales of shelled hemp seed will continue at existing rates or increase; the ability to complete the sales of all bulk hemp seed purchase orders; and the risk that any of the potential applications, including its application to obtain a Standard Processing License, may not receive all required regulatory or legal approval. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, Naturally Splendid undertakes no obligation to publicly update or revise forward-looking information.


Click here to connect with Naturally Splendid (TSXV:NSP) for an Investor Presentation.


Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less